Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giovarelli

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Cancer Research|November 1, 1993
Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinomaF Cavallo, F Di Pierro, M Giovarelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1994
IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cellsM Ferrantini, M Giovarelli, A Modesti, et al.
Blood|May 11, 1999
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15T Musso, L Calosso, M Zucca, et al.
Journal of Biological Response Modifiers|December 1, 1989
Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinomaP Musiani, E De Campora, S Valitutti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1993
Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophagesM C Bosco, T Musso, G L Gusella, et al.
British Journal of Cancer|November 1, 1996
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cellsP Nanni, C De Giovanni, L Landuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4F Pericle, M Giovarelli, M P Colombo, et al.
Human Gene Therapy|June 1, 1995
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growthP L Lollini, C De Giovanni, L Landuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memoryM Giovarelli, P Musiani, A Modesti, et al.
Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Cancer Research|November 1, 1993
Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinomaF Cavallo, F Di Pierro, M Giovarelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1994
IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cellsM Ferrantini, M Giovarelli, A Modesti, et al.
Blood|May 11, 1999
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15T Musso, L Calosso, M Zucca, et al.
Journal of Biological Response Modifiers|December 1, 1989
Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinomaP Musiani, E De Campora, S Valitutti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1993
Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophagesM C Bosco, T Musso, G L Gusella, et al.
British Journal of Cancer|November 1, 1996
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cellsP Nanni, C De Giovanni, L Landuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4F Pericle, M Giovarelli, M P Colombo, et al.
Human Gene Therapy|June 1, 1995
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growthP L Lollini, C De Giovanni, L Landuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memoryM Giovarelli, P Musiani, A Modesti, et al.
Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.
Pageof 12